For 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]
Science Quickly
00:00
Introduction
Dr. Temi Fullorani, Vice President and Head of U.S. Medical and Clinical Affairs Vaccines at GSK, discusses the availability of RSV vaccinations in the United States and her career in disease prevention and public health.
Transcript
Play full episode
